{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:20:54Z","timestamp":1755224454942,"version":"3.43.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Melanoma differentiation\u2013associated gene 5 (MDA5)-associated rapidly progressive interstitial lung disease (RPILD) is a rare and life-threatening condition with no standardized treatment protocol. We report a case of successful treatment using a novel combination therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 69-year-old female presented with progressive dyspnea and chest tightness that had persisted for 1 year but significantly worsened over the 20 days before admission. The recent exacerbation was accompanied by coughing, expectoration, and fatigue.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Following a comprehensive evaluation including chest computed tomography imaging, laboratory tests, and autoantibody profiling, the patient was diagnosed with MDA5-associated RPILD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with high-dose methylprednisolone pulse therapy, cyclophosphamide, and telitacicept (a novel TACI-Fc fusion protein).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After treatment, the patient\u2019s oxygenation index improved from 174 to 306\u2009mm Hg. Follow-up chest computed tomography showed near-complete resolution of bilateral lung inflammation. Pulmonary function tests demonstrated improvement, with diffusing capacity for carbon monoxide reaching 63.6% of the predicted value at 6-month follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case suggests that combination therapy including telitacicept may be effective for MDA5-associated RPILD. Further research is needed to confirm these findings and elucidate the underlying mechanisms of action.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043293","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:00:54Z","timestamp":1752516054000},"page":"e43293","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Telitacicept combined with conventional therapy successfully treated MDA5-associated RPILD: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5264-9681","authenticated-orcid":false,"given":"Lang","family":"Zhang","sequence":"first","affiliation":[{"name":"Zunyi Medical University, Zunyi City, Guizhou Province, China"},{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Luo","sequence":"additional","affiliation":[{"name":"Zunyi Medical University, Zunyi City, Guizhou Province, China"},{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingqin","family":"Shao","sequence":"additional","affiliation":[{"name":"Zunyi Medical University, Zunyi City, Guizhou Province, China"},{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Hu","sequence":"additional","affiliation":[{"name":"Zunyi Medical University, Zunyi City, Guizhou Province, China"},{"name":"Department of Radiology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-4746","authenticated-orcid":false,"given":"Xin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guizhou Provincial People\u2019s Hospital, Guiyang, Guizhou Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies.","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250812","first-page":"120","article-title":"Progress in diagnosis and treatment of interstitial lung disease in patients with melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.","volume":"36","author":"Yang","year":"2021","journal-title":"West China Med J"},{"key":"R3-20250812","first-page":"1886","article-title":"One case of anti-MDA5 antibody-positive dermatomyositis complicated by hemophagocytic syndrome and literature review.","volume":"24","author":"Lu","year":"2020","journal-title":"Chin J Lab Diagn"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","article-title":"HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody.","volume":"105","author":"Tanizawa","year":"2011","journal-title":"Respir Med"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","article-title":"Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease.","volume":"50","author":"Romero-Bueno","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R6-20250812","first-page":"5386797","article-title":"Effective administration of rituximab in anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease and refractory cutaneous involvement: a case report and literature review.","volume":"2017","author":"Ogawa","year":"2017","journal-title":"Case Rep Rheumatol"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coi.2008.01.002","article-title":"MDA5\/RIG-I and virus recognition.","volume":"20","author":"Takeuchi","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","article-title":"A balancing act: MDA5 in antiviral immunity and autoinflammation.","volume":"27","author":"Dias Junior","year":"2019","journal-title":"Trends Microbiol"},{"key":"R10-20250812","first-page":"143","article-title":"Anti-MDA5 antibody related dermatomyositis.","volume":"13","author":"Yang","year":"2019","journal-title":"Chin J Allergy Clin Immunol"},{"key":"R11-20250812","first-page":"2846","article-title":"A case of anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease and a literature review.","volume":"34","author":"Xue","year":"2021","journal-title":"J Med Theory Pract"},{"key":"R12-20250812","first-page":"193","article-title":"Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations.","volume":"26","author":"Aoyama","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"R13-20250812","first-page":"704","article-title":"Research progress of dermatomyositis-related autoantibodies in interstitial lung disease.","volume":"52","author":"Luo","year":"2024","journal-title":"Tianjin Med J"},{"key":"R14-20250812","first-page":"106","article-title":"Advances in diagnosis and treatment of anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease.","volume":"29","author":"Jiang","year":"2023","journal-title":"J Crit Care Intern Med"},{"key":"R15-20250812","first-page":"1048","article-title":"Research progress on anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.","volume":"37","author":"Wu","year":"2022","journal-title":"Clin Focus"},{"key":"R16-20250812","first-page":"5","article-title":"Advances in the treatment of autoimmune diseases with telitacicept.","volume":"45","author":"Qin","year":"2024","journal-title":"World Clin Drug"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/icb.2012.10","article-title":"Role of type I interferons in the activation of autoreactive B cells.","volume":"90","author":"Kiefer","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"39904","DOI":"10.1038\/srep39904","article-title":"IFN type I and II induce BAFF secretion from human decidual stromal cells.","volume":"7","author":"Lundell","year":"2017","journal-title":"Sci Rep"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.4049\/jimmunol.177.10.7164","article-title":"Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism.","volume":"177","author":"Kato","year":"2006","journal-title":"J Immunol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrrheum.2013.168","article-title":"Emerging cell and cytokine targets in rheumatoid arthritis.","volume":"10","author":"Burmester","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis.","volume":"115","author":"Seyler","year":"2005","journal-title":"J Clin Invest"},{"key":"R22-20250812","first-page":"919","article-title":"Inhibitory effect of rh TACI-Ig on anti-CD3 antibody induced T lymphocytes proliferation and activation.","volume":"51","author":"Yang","year":"2016","journal-title":"Acta Univ Medicinalis Anhui"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"108796","DOI":"10.1016\/j.biopha.2019.108796","article-title":"BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway.","volume":"114","author":"Hu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R24-20250812","first-page":"475","article-title":"Research status of B lymphocyte stimulating factor and its receptor in lupus nephritis.","volume":"39","author":"Chen","year":"2024","journal-title":"Clin Focus"},{"key":"R25-20250812","first-page":"2356","article-title":"B-lymphocyte-targeted biologics for systemic lupus erythematosus: belimumab and telitacicept.","volume":"20","author":"Zhang","year":"2022","journal-title":"Cent South Pharm"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/TP.0000000000002686","article-title":"APRIL\/BLyS blockade reduces donor-specific antibodies in allosensitized mice.","volume":"103","author":"Wilson","year":"2019","journal-title":"Transplantation"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cytogfr.2008.04.006","article-title":"TACI, an enigmatic BAFF\/APRIL receptor, with new unappreciated biochemical and biological properties.","volume":"19","author":"Mackay","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"1169084","DOI":"10.3389\/fimmu.2023.1169084","article-title":"Telitacicept for autoimmune nephropathy.","volume":"14","author":"Cai","year":"2023","journal-title":"Front Immunol"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s40265-021-01591-1","article-title":"Telitacicept: first approval.","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"R30-20250812","first-page":"51","article-title":"Research progress of telitacicept in IgA nephropathy and lupus nephritis.","volume":"32","author":"Yang","year":"2022","journal-title":"China J Mod Med"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2019.243543","article-title":"The regulation and function of CD20: an \u201cenigma\u201d of B-cell biology and targeted therapy.","volume":"105","author":"Pavlasova","year":"2020","journal-title":"Haematologica"},{"key":"R32-20250812","doi-asserted-by":"crossref","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies.","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"key":"R33-20250812","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress.","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:01:10Z","timestamp":1755018070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":33,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043293","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}